Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 3, 2007, Pages 262-271

  Kuno, Atsushi ^a   Critz, Stuart D ^b   Cui, Lin ^a   Solodushko, Victoriya ^a   Yang, Xi Ming ^a   Krahn, Thomas ^c   Albrecht, Barbara ^c   Philipp, Sebastian ^a   Cohen, Michael V ^a   Downey, James M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c BAYER PHARMA AG   (Germany)

Author keywords

Adenosine A2b receptors; BAY 60 6583; NECA; Preconditioning; Protein kinase C

Indexed keywords

ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; BAY 606583; CHELERYTHRINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISCHEMIC PRECONDITIONING; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RABBIT; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

ACETAMIDES; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ALKALOIDS; AMINOPYRIDINES; ANIMALS; BENZOPHENANTHRIDINES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PERFUSION; PHOSPHORYLATION; PROTEIN KINASE C; PURINES; RABBITS; RECEPTOR, ADENOSINE A2B; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

ORYCTOLAGUS CUNICULUS;

EID: 34548223683     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.05.016     Document Type: Article

References (34)

1. Hausenloy D.J., Tsang A., Mocanu M.M., and Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am. J. Physiol. 288 (2005) H971-H976
2. 2b receptor cascade. Cardiovasc. Res. 70 (2006) 308-314
3. Yang X.-M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J. Am. Coll. Cardiol. 44 (2004) 1103-1110
4. Solenkova N.V., Solodushko V., Cohen M.V., and Downey J.M. Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am. J. Physiol. 290 (2006) H441-H449
5. Kin H., Zatta A.J., Lofye M.T., Amerson B.S., Halkos M.E., Kerendi F., et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc. Res. 67 (2005) 124-133
6. Kitakaze M., Funaya H., Minamino T., Node K., Sato H., Ueda Y., et al. Role of protein kinase C-α in activation of ecto-5′-nucleotidase in the preconditioned canine myocardium. Biochem. Biophys. Res. Commun. 239 (1997) 171-175
7. Schulz R., Post H., Vahlhaus C., and Heusch G. Ischemic preconditioning in pigs: a graded phenomenon. Its relation to adenosine and bradykinin. Circulation 98 (1998) 1022-1029
8. Goto M., Cohen M.V., Van Wylen D.G.L., and Downey J.M. Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection. J. Mol. Cell. Cardiol. 28 (1996) 447-454
9. Harrison G.J., Willis R.J., and Headrick J.P. Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc. Res. 40 (1998) 74-87
10. National Research Council. Guide for the care and use of laboratory animals. 7th ed (1996), National Academy Press, Washington, D.C.
11. 2B adenosine receptors. Circulation 115 (2007) 1581-1590
12. 2a adenosine receptors. Mol. Pharmacol. 42 (1992) 123-133
13. Yang X.-.M., Krieg T., Cui L., Downey J.M., and Cohen M.V. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J. Mol. Cell. Cardiol. 36 (2004) 411-421
14. Inagaki K., Hahn H.S., Dorn II G.W., and Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and ε-protein kinase C activator. Circulation 108 (2003) 869-875
15. Inagaki K., Chen L., Ikeno F., Lee F.H., Imahashi K.-i., Bouley D.M., et al. Inhibition of δ-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 108 (2003) 2304-2307
16. Schulte G., and Fredholm B.B. Diverse inhibitors of intracellular signalling act as adenosine receptor antagonists. Cell. Signal. 14 (2002) 109-113
17. Nordstedt C., Kvanta A., Van der Ploeg I., and Fredholm B.B. Dual effects of protein kinase-C on receptor-stimulated cAMP accumulation in a human T-cell leukemia line. Eur. J. Pharmacol. 172 (1989) 51-60
18. Nash M.S., Wood J.P.M., and Osborne N.N. Protein kinase C activation by serotonin potentiates agonist-induced stimulation of cAMP production in cultured rat retinal pigment epithelial cells. Exp. Eye Res. 64 (1997) 249-255
19. 2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells. J. Neurochem. 91 (2004) 1180-1190
20. 2B adenosine receptors. J. Med. Chem. 43 (2000) 1165-1172
21. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ. Res. 88 (2001) 520-528
22. 2B receptor activation mimics postconditioning in a rabbit infarct model. Circulation 114 Suppl II (2006) II-14-II-15
23. 2B receptor recruits divergent pathways to regulate ERK1/2 and p38. Exp. Cell Res. 290 (2003) 168-176
24. 2B adenosine receptor stimulation. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2068-2073
25. 3 receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol. Pharmacol. 58 (2000) 477-482
26. 2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J. Pharmacol. Exp. Ther. 280 (1997) 301-309
27. 2A receptor agonist, in reperfused canine myocardium. Am. J. Physiol. 288 (2005) H1851-H1858
28. 2-receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J. Cardiovasc. Pharmacol. 22 (1993) 89-96
29. 2 receptors. J. Cardiovasc. Pharmacol. 38 (2001) 474-481
30. 3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am. J. Physiol. 285 (2003) H607-H613
31. 3 receptor activation protects the myocardium from reperfusion/reoxygenation injury. Am. J. Physiol. 283 (2002) H1307-H1313.
32. Xu Z., Park S.-.S., Mueller R.A., Bagnell R.C., Patterson C., and Boysen P.G. Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc. Res. 65 (2005) 803-812
33. 2B adenosine receptor protects against inflammation and excessive vascular adhesion. J. Clin. Invest. 116 (2006) 1913-1923
34. 2B receptors. Am. J. Physiol. 282 (2002) H437-H444